You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
大博醫療(002901.SZ)半年度淨利潤升18.46%至2.08億元
格隆匯 08-20 17:15

格隆匯8月20日丨大博醫療(002901.SZ)發佈2019年半年度報告,實現營業收入5.43億元,同比增長54.27%;歸屬於上市公司股東的淨利潤2.08億元,同比增長18.46%;歸屬於上市公司股東的扣除非經常性損益的淨利潤1.91億元,同比增長24.90%;基本每股收益0.5166元。

2019年上半年,高值醫用耗材領域改革持續推進,帶量採購的試點以及兩票制的推行,對高值耗材行業的發展產生了深遠影響。公司按照既定的發展戰略與經營目標,適時調整經營模式,立足骨科,積極佈局微創外科、神經外科、齒科及運動醫學,在全體員工的共同努力下,各項業務有序推進。

報告期內,公司積極推進募投項目建設,物流配送網點持續增加,創傷脊柱骨科耗材擴產項目關節假體投產項目研發中心建設項目三個募投項目的主體工程建設已開始施工。隨着募投項目建設的有序進行,營銷網絡逐步完善,創傷類及脊柱類植入性高值耗材的產能將得到釋放,關節類產品結構將更為豐富,同時,公司的研發實力有望得到進一步提升。

研發方面,公司利用已有的技術、人才、資金、體系優勢,加大研發投入,加快產品開發及升級迭代。報告期內,公司新取得5個三類註冊證,包括鈷鉻鉬金屬鎖定接骨螺釘、脊柱椎間融合器、不可吸收帶線錨釘等,進一步豐富了公司的產品線。截止目前,公司已取得專利證書的專利170項,其中發明專利25項,實用新型專利139項,外觀設計專利6, 公司持有國內三類醫療器械註冊證62個,二類醫療器械註冊證23個,一類醫療器械備案憑證174個。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account